Sanne Smith-Apeldoorn
PhD/Epidemiology Student and Psychiatry Resident at University Medical Center Groningen (UMCG) / University of Groningen
Key Impact
She is a clinical researcher publishing systematic reviews and trials on ketamine and esketamine for treatment-resistant depression, with work touching safety in psychosis and medication interactions in psychedelic-adjacent psychiatric treatment.
Background & Research
Sanne Smith-Apeldoorn is a Dutch psychiatrist in training and epidemiology/PhD researcher at the University Medical Center Groningen and University of Groningen. Her research focuses on ketamine and esketamine for difficult-to-treat depression, including efficacy, safety, tolerability, and clinical implementation. She is also involved in broader mood, anxiety, and psychedelic treatment research at UMCG.
Collaboration Network
3 collaborators· click a node to visit their profile
Full network →